ANAVEX2-73 Study in Parkinson's Disease Dementia

NCT03774459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinsons Disease With Dementia

Interventions

DRUG: High dose ANAVEX2-73
DRUG: Mid dose ANAVEX2-73
DRUG: Placebo oral capsule

Sponsor

Anavex Life Sciences Corp.

Collaborators

[object Object]